Ferroptosis: a potential target for the treatment of atherosclerosis

Chengyi Li1, Ran Liu1, Zhenyu Xiong1

  • 1School of Medicine, Yangtze University, Jingzhou 434020, China.

PubMed

Insights

Ferroptosis, an iron-dependent cell death, drives atherosclerosis progression by increasing oxidative stress and lipid peroxidation. Targeting ferroptosis offers a novel therapeutic strategy for cardiovascular events like heart attack and stroke.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Cell Death Mechanisms

Background:

  • Atherosclerosis (AS) is a primary cause of heart attack and stroke, marked by plaque instability and cell death.
  • Ferroptosis, a newly identified iron-dependent cell death, plays a significant role in AS progression.
  • Elevated intracellular iron in AS exacerbates oxidative stress, lipid peroxidation, and inflammation, impacting vascular cell function.

Approach:

  • This review systematically examines the intricate relationship between ferroptosis and atherosclerosis.
  • It elucidates the molecular mechanisms linking ferroptosis to AS development and progression.
  • The review proposes ferroptosis inhibition as a potential therapeutic avenue for AS.

Key Points:

  • Ferroptosis contributes to AS by increasing reactive oxygen species (ROS) and lipid peroxidation.
  • Accumulated iron activates pathways implicated in AS, including abnormal lipid metabolism and inflammation.
  • Ferroptosis dysregulates the function of macrophages, vascular smooth muscle cells, and endothelial cells.

Conclusions:

  • Understanding the molecular interplay between ferroptosis and AS is crucial.
  • Targeting ferroptosis presents a promising strategy to inhibit AS progression and prevent cardiovascular events.
  • Further research into ferroptosis pathways could unlock novel treatments for atherosclerosis.